ReviewCancers2021

Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

Edith Borcoman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.